Table 2 |
|||
|
Serum alanine aminotransferase (ALT) measures (intent to treat analysis) |
|||
|
Serum ALT (IU/L) |
|||
|
|
|||
|
Acetaminophen group |
Placebo Group |
p-value* |
|
|
|
|||
|
Day 0: |
|||
|
Mean ± SD |
49 ± 38 |
47 ± 37 |
0.398 |
|
Range |
4–189 |
8–175 |
|
|
n |
308 |
135 |
|
|
Day 2: |
|||
|
Mean ± SD |
45 ± 38 |
46 ± 34 |
0.949 |
|
Range |
7–292 |
6–174 |
|
|
n |
287 |
124 |
|
|
Day 3: |
|||
|
Mean ± SD |
45 ± 36 |
50 ± 38 |
0.245 |
|
Range |
7–230 |
6–242 |
|
|
n |
274 |
118 |
|
|
Day 4: |
|||
|
Mean ± SD |
48 ± 39 |
52 ± 43 |
0.411 |
|
Range |
6–264 |
8–288 |
|
|
n |
267 |
115 |
|
|
Day 5: |
|||
|
Mean ± SD |
57 ± 45 |
55 ± 48 |
0.706 |
|
Range |
7–312 |
7–282 |
|
|
n |
261 |
114 |
|
|
|
|||
|
*Standardized values based upon upper limit of normal were used to calculate p-values. Normal ranges for CARES: ALT 5–40 IU/L male and 5–36 IU/L female. Two different labs were used by RCKC, normal ranges: ALT 0–50 IU/L and 2–60 IU/L male, 2–40 IU/L female. |
|||
|
Kuffner et al. BMC Medicine 2007 5:13 doi:10.1186/1741-7015-5-13 |
|||